PKN, a novel protein kinase with a catalytic domain homologous to that of the protein kinase C (PKC) family and unique Nterminal leucine-zipper-like sequences, was identified by molecular cloning from a human hippocampus cDNA library Biochem. Biophys. Res. Commun. 199,[897][898][899][900][901][902][903][904]. Recently we partially purified recombinant PKN from COS7 cells transfected with the cDNA construct encoding human PKN, and demonstrated that the recombinant PKN was activated by unsaturated fatty acids and limited proteolysis [Mukai, Kitagawa, Shibata et al. (1994) Biochem. Biophys. Res. Commun. 204,[348][349][350][351][352][353][354][355][356]. The present work has focused on the further purification and characterization of PKN from native rat tissue. Immunochemical measurement revealed that PKN was found in every tissue, and was especially abundant in testis, spleen and brain; subcellular fractionation of rat brain showed that half of the PKN was localized in the soluble cytosolic fraction. PKN was purified approx. 8000-fold to apparent homogeneity from the cytosolic fraction of rat testis by DEAE- cellulose chromatography, ammonium sulphate fractionation and chromatography on butyl-Sepharose, heparin-Sepharose, Mono Q and protamine-CH-Sepharose. The enzyme migrates as a band of apparent molecular mass 120 kDa. Using serinecontaining peptides based on the pseudosubstrate sequence of PKC-6 as phosphate acceptors, the kinase activity was stimulated several-fold by 40 pesM unsaturated fatty acids or by detergents such as 0.04 % sodium deoxycholate and 0.004 % SDS. In the absence of modifiers, protamine sulphate, myelin basic protein and synthetic peptides based on the pseudosubstrate site of PKCs or ribosomal S6 protein were good substrates for phosphorylation by the kinase. In the presence of 40 ,uM arachidonic acid the kinase activity of PKN for these phosphate acceptors was increased 2-18-fold. The autophosphorylation activity of purified PKN was partially inhibited by pretreatment with alkaline phosphatase. These properties appear to distinguish PKN from many protein kinases isolated previously.
INTRODUCTION
Almost all protein kinases have sequence similarities in their catalytic domains, and screening of cDNA libraries with probes corresponding to the catalytic domains of protein kinases has been a basic strategy to identify a novel protein kinase [1] . We screened a human hippocampus cDNA library by utilizing the catalytic domain of protein kinase C (PKC)-,1II as a probe, and found a novel protein kinase, designated PKN, with a catalytic domain homologous to that of the PKC family and unique Nterminal leucine-zipper-like sequences [2] . As the primary structure of PKN does not contain consensus Ca2l or phorbol ester binding motifs which are observed in the PKC family [3] , PKN may possess a distinct mechanism of regulation from that of PKC.
Using partially purified recombinant PKN from cDNAconstruct-transfected COS7 cells, we have shown that Ca2+/phosphatidylserine (PS)/diolein could not activate the kinase activity of PKN, but unsaturated fatty acids enhanced the kinase activity between several-fold and approx. 50-fold [4] , suggesting that PKN is a fatty-acid-dependent kinase. Furthermore, studies of substrate specificity showed that the recombinant PKN phosphorylated synthetic peptides based on the PKC pseudosubstrate sequence in the presence of arachidonic acid. For those assays the soluble cytosolic fraction of cDNAconstruct-transfected COS7 cells was used as the enzyme source, but most of the recombinant PKN was recovered in the insoluble fraction, suggesting that the high-level expression might result in cellulose chromatography, ammonium sulphate fractionation and chromatography on butyl-Sepharose, heparin-Sepharose, Mono Q and protamine-CH-Sepharose. The enzyme migrates as a band of apparent molecular mass 120 kDa. Using serinecontaining peptides based on the pseudosubstrate sequence of PKC-6 as phosphate acceptors, the kinase activity was stimulated several-fold by 40 pesM unsaturated fatty acids or by detergents such as 0.04 % sodium deoxycholate and 0.004 % SDS. In the absence of modifiers, protamine sulphate, myelin basic protein and synthetic peptides based on the pseudosubstrate site of PKCs or ribosomal S6 protein were good substrates for phosphorylation by the kinase. In the presence of 40 ,uM arachidonic acid the kinase activity of PKN for these phosphate acceptors was increased 2-18-fold. The autophosphorylation activity of purified PKN was partially inhibited by pretreatment with alkaline phosphatase. These properties appear to distinguish PKN from many protein kinases isolated previously.
incorrectly folded molecules. In addition, this product of transfected cells might be different from native PKN with regard to post-translational modification. Moreover, using partially purified recombinant PKN as the enzyme source, there was the possibility of contamination with other protein kinases or phosphatases or with endogenous inhibitors. As a consequence, purification and characterization of a native PKN was necessary in order to investigate the physiological enzymic properties of the enzyme.
In this paper we show (i) the tissue and subcellular distributions of PKN by immunoblot analysis; (ii) the purification to homogeneity of native PKN from rat testis; (iii) the effects of various modifiers on the kinase activity of PKN using various substrates; and (iv) the effect of preincubation with phosphatase on the autophosphorylation activity of PKN.
EXPERIMENTAL

Materials
Polyvinylidene difluoride membrane (Immobilon) and an enhanced chemiluminescence Western blotting detection kit were purchased from Millipore and Amersham respectively. DEAEcellulose (DE52) and P81 filter paper were purchased from Whatman. Protein A-Sepharose, butyl-Sepharose, Mono Q HR5/5, activated CH-Sepharose 4B and HiTrap-heparinSepharose were purchased from Pharmacia LKB Biotechnology Inc. Alkaline phosphatase (Escherichia coli C75) was purchased from Takara Shuzo Co., Kyoto, Japan. Calmodulin was purified Abbreviations used: PKC, protein kinase C; PS, phosphatidylserine; DTT, dithiothreitol; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PA, phosphatidic acid; PI, phosphatidylinositol; DOC, sodium deoxycholate; PKA, cyclic AMP-dependent protein kinase; MAP kinase, mitogen-activated protein kinase.
* To whom correspondence should be addressed.
from rat brain using a phenyl-Sepharose column, as described [5] . 
Immunoblotting
Antisera against the N-terminal region or C-terminal region of PKN were obtained by immunizing rabbits with bacterially synthesized fragments of rat PKN as described [4] . Samples were subjected to SDS/PAGE and subsequently transferred to a polyvinylidene difluoride membrane. The membrane was then blocked with PBS (20 mM sodium phosphate, pH 7.5, 137 mM NaCl) containing 0.05 % Triton X-100 (PBS-T) and 5 % normal goat serum for 1 h at room temperature. The membrane was then incubated in PBS-T and the relevant primary antiserum (1:1000 dilution) for 1 h at room temperature. The membrane was washed three times (5 min each time) in PBS-T before incubating the blot in PBS-T containing a goat anti-rabbit IgG conjugated to horseradish peroxidase at 1:1000 dilution for 30 min. After this incubation, the membrane was subjected to three 10 min washes in PBS-T. Blots were developed by the enhanced chemiluminescence method.
Quantification of PKN
Contents of PKN in various tissues and subcellular fractions were determined by immunochemical analysis using antiserum against the N-terminal region of PKN as described [9] . Various amounts (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) Subcellular fractionation of rat brain Subcellular fractionation of rat brain was done by the method described by Ueda et al. [10] . Rats were decapitated and brains were quickly removed. All subsequent operations were carried out at 0-4 'C. Starting from 1.6 g of the wet tissue, nuclear (P1 fraction), crude mitochondrial (P2 fraction), microsomal (P3 fraction) and soluble (S fraction) fractions were obtained as presented in Table 2 . The P2 fraction was fractionated by the method described by Ueda et al. [10] . Starting from the P2 fraction suspended in 6 ml of sucrose buffer solution, four subfractions (A, B, C and D) were obtained as presented in Table 2 .
Purfficatlon of PKN All procedures were carried out at 0-4 'C. Rat testis (60 g fresh weight) was added to 300 ml of homogenization buffer (50 mM Tris/HCl, pH 7.5, 5 mM EDTA, 5 mM EGTA, 0.5 mM DTT, 10 ,tg/ml leupeptin, 0.02 % NaN3 and 1 mM PMSF) and homogenized for 10 min with a Polytron homogenizer (Kinematica). The resulting crude homogenate was then centrifuged at 10000 g for 1 h. The supernatant was recentrifuged at 24000 g for 1 h, and the supernatant was loaded on to a 180 ml DE52 column equilibrated in buffer B (25 mM Tris/HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 0.5 mM DTT, 100 ng/ml leupeptin and 0.02 % NaN3). The column was then washed with 20 column vol. of buffer B containing 50 mM NaCl and eluted with buffer B containing 200 mM NaCl. The DE52 fraction was immediately subjected to ammonium sulphate fractionation. Solid ammonium sulphate was added to the fraction to obtain 40 % saturation. The solution was left to stand, with stirring, for 30 min and was then centrifuged at 15000 g for 1 h. The precipitate was resuspended in buffer B containing 20% ammonium sulphate and loaded on to a 20 ml butyl-Sepharose column equilibrated with the same buffer. The column was washed with 20 column vol. of the same buffer and 3 column vol. of buffer B containing 15 % ammonium sulphate, and PKN was eluted with 3 column vol. of buffer B containing 10% ammonium sulphate. The fraction from butyl-Sepharose was dialysed against buffer B, and then divided into two equal portions. One sample was loaded on to a 5 ml HiTrap-heparin-Sepharose column equilibrated with buffer B, which was connected to a Pharmacia FPLC system. The column was then washed with 5 column vol. of the same buffer, and PKN was eluted from the column by application of a 50 ml linear concentration gradient of NaCl (0-0.6 M) in buffer B at a flow rate of 60 ml/h. Fractions of 1 ml each were collected, and a major peak ofPKN appeared in fractions 34-41; these fractions were pooled. Another sample was subjected to the same chromatography, and the resultant fractions were pooled as described above. The two pooled fractions were added together, dialysed against buffer B, and then loaded on to a MonoQ 5/5HR column equilibrated with the same buffer using an FPLC system. The column was then washed with 10 column vol. of the same buffer, and PKN was eluted from the column by application of a 40 ml linear concentration gradient ofNaCl (0-0.4 M) in buffer B at a flow rate of 120 ml/h. Fractions of 1 ml were collected, and a major peak of PKN appeared in fractions 25-30. These fractions were pooled and loaded on to a 4 ml protamine-CHSepharose column equilibrated with buffer B. The column was washed with 3 vol. of the same buffer and 6 vol. of buffer B containing 0.5 M NaCl, and eluted with a 16 ml linear gradient of NaCl (0.5-2 M) and 10 ml of buffer B containing 2 M NaCl.
Fractions of 1 ml were collected, and a major peak of PKN appeared in fractions [16] [17] [18] [19] [20] .
Enzyme assays
The enzyme was incubated for 5 Estimated from specific activity. t Protein content was determined after concentration using a centrifugal concentrator. gels was done using a silver stain kit from Wako Pure Chemical, Tokyo, Japan.
RESULTS
Tissue distribution and subcellular distribution of PKN PKN was found in every tissue studied and was most enriched in the testis, making up 0.02 % of the total protein in this tissue (Table 1) . To investigate the subcellular distribution of PKN in native rat tissues, we performed subcellular fractionation of PKN from rat brain ( Table 2) . When the homogenates of rat brain were fractionated into P1 (nuclei and cell debris), P2 (myelin, mitochondria and synaptosomes), P3 (microsomes) and S (soluble cytosol) fractions, 48 % of the PKN was found in the S fraction. Among the three particulate fractions, approx. 60 % of the PKN was in the P2 fraction. Further fractionation of P2 into myelin (fraction A), endoplasmic reticulum and Golgi complex (fraction B), synaptosomes (fraction C) and mitochondria (fraction D) revealed that each subfraction contained a roughly equal amount of PKN. The subcellular fractionation pattern of PKN was distinct from those of PKC or cyclic AMPdependent protein kinase (PKA), which are mostly associated with synaptosomes [13, 14] . Although in cDNA-construct-transfected COS7 cells or insect cells most of the PKN was recovered in the Triton/salt-insoluble fraction as previously described [4] , native PKN was localized in the soluble cytosol rather than in insoluble particulate fractions. Thus we used the S fraction of rat testis homogenate for purification of native PKN.
Purification of PKN
In order to monitor the efficiency of purification of PKN we used a specific antiserum raised against the N-terminal region of the enzyme, and the catalytic activity of PKN was assessed by the arachidonic acid-dependent phosphorylation of PKC-8 peptide. The purification of PKN from rat testis is summarized in Table  3 (see the Experimental section for details). Five column chromatography steps yielded approx. 12,g of PKN purified about 8000-fold to apparent homogeneity from 60 g ofstarting material.
As shown in Table 3 , the total PKC-8 peptide kinase activity of the fraction from ammonium sulphate precipitation was higher than that of the fraction from the DE52 column, and the specific activity was decreased after butyl-Sepharose chromatography. This was due to contaminating kinases that were present at early stages of purification and were activated by ammonium sulphate, as shown by the following. (i) The addition of ammonium sulphate to 20 % saturation stimulated the PKC-8 peptide kinase activity of the fraction from the DE52 column by 1.6-2.0-fold, but could not increase the activity of fractions after the butylSepharose column (results not shown). (ii) We confirmed that each step was effective for purification of immunoreactive PKN by Western blotting.
The elution profiles of the last three chromatographic steps shown in Figure 1 were highly reproducible, and the PKC-8 peptide kinase activity was closely correlated with the appearance of immunoreactive bands (Figure 2 ). The final step, i.e. chromatography on protamine-CH-Sepharose, fractions from which were analysed by SDS/10 %-PAGE and silver staining ( Figure  2 ), resulted in a marked purification (approx. 100-fold). PKN bound to the column very tightly and was eluted by 2 M NaCl. Purified PKN eluted from the final chromatography column was resolved in a single band, of apparent molecular mass 120 kDa, which reacted with the antibody. Effects of modfflers on PKN activity As shown in about 2-fold by single-stranded or double-stranded DNA. Unsaturated fatty acids, including arachidonic acid, linoleic acid and oleic acid, enhanced the kinase activity about 7-9-fold, whereas saturated fatty acids such as palmitic acid were less effective. When the PKC-8 peptide was employed as the phosphate acceptor, half-maximal activation (A,05) was achieved at about 7-8 ,M arachidonic acid, and maximal activation occurred at 40 uM (Figure 3a ). Lysophospholipids such as lysophosphatidylcholine (lyso-PC), lyso-PS, lysophosphatidic acid (lyso-PA) and lysophosphatidylinostitol (lyso-PI) at 8 /ug/ml were capable of enhancing the kinase activity by 2-5-fold (Table 4 ).
The AO.5 values of these modifiers are shown in Table 5 .
We investigated the effects of various detergents on the kinase activity of PKN (Table 6 ). Interestingly, steroid-type detergents such as sodium cholate, digitonin, CHAPS and especially sodium deoxycholate (DOC) at 0.04 % (w/v) enhanced the kinase activity approx. 7-fold. Moreover, ionic detergents such as SDS at 0.040% (w/v) enhanced the kinase activity, whereas non-ionic detergents, such as Triton X-100, octyl glucoside, dodecyl maltoside and Lubrol PX, were only slightly stimulatory. Higher concentrations of detergents inhibited kinase activity ( Figure  3b ). Several compounds were observed that inhibited the kinase activity of PKN (Table 4) . As shown in Figure 3( > 97% by 1 mM Mn2+ or by 10 mM Ca2+ (Figure 3c ). The enzyme was also inhibited by NaCl in a dose-dependent manner, with an IC50 value of 160 mM ( Figure 3d , Table 5 ).
Effects of dilution of assay mixture on the activation of PKN by modifiers The reversibility of the PKN activation reaction was examined in the following way. A complex between PKN and the modifier was formed by mixing the two. The ability of the PKN-modifier complex to dissociate and thus restore PKN basal activity was then assessed by diluting the mixture and determining the extent of PKN activation. The results presented in Figure 4 show that PKN activity was decreased upon dilution of the PKN-modifier complex, suggesting that the modifier reversibly binds to PKN to form an active PKN-modifier complex.
Substrate specificity
As described above, the C-terminal region ofPKN is homologous to the catalytic domain of the PKC family [2] . Therefore several proteins and peptides which have been shown to be good substrates for PKC were tested as substrates for purified PKN. As expected, we found the PKC pseudosubstrate sequencederived peptides to be excellent substrates for native PKN (Table  7 ). In the absence of arachidonic acid, protamine sulphate and PKC-8 peptide were good substrates for phosphorylation by the kinase. In the presence of 40 [Cation] (#M) [NaCII (mM) Figure 3 Effects of fatty acids, detergents, bivalent cations and NaCI on PKN activity [4] . As shown in a previous study [4] , PKN was activated by unsaturated fatty acids. In the present paper we have also shown that several detergents stimulated the activity ofPKN. Moreover, we observed that lysophospholipids that are known as biological detergents also enhanced the activity, whereas phospholipids such as PC or PE did not. It is well known that fatty acids and detergents aggregate to form micelles in aqueous solution due to their amphiphilic structure, but are in monomeric form under critical micelle concentrations [16] . Thus we suggest that the activation of PKN by fatty acids or detergents at low concentrations is due to the interaction of PKN with these amphiphilic molecules, since PKN binds to hydrophobic affinity resins, demonstrating the presence of exposed hydrophobic sites. High concentrations of detergents inhibited PKN, which may be caused by the denaturation of the enzyme or its incorporation into detergent micelles. The observations that fatty acids and detergents can alter PKN activity suggest that endogenous surfactants such as lyso-PC or amphiphiles such as arachidonic acid might be modulators of PKN in vivo.
Arachidonic acid is a major component of lipid, and is found abundantly in the sn-2 chains of phospholipids. Arachidonic acid is liberated to the unesterified form during selective hydrolysis by the action of phospholipase A2 [17] . In its unesterified state arachidonic acid is believed to be important in signal transduction as a precursor of a variety of biological products, such as prostaglandins and leukotrienes [18] . Several laboratories have reported that arachidonic acid, and to a lesser extent related fatty acids, are able to activate several signal transduction mechanisms independent of enzymic pathways, such as the activation of K+ channels in cardiac and smooth muscle cells [19, 20] ; amplification of Ca2+ entry through N-methyl-D-aspartate receptor-oriented Ca2+ channels [21] ; enhancement of long-term potentiation [22] ; inhibition of Ras-GTPase activating protein [23] ; stimulation of Ras-GTPase inhibiting protein [24] ; activation of a GTP binding protein in the neutrophil plasma membrane [25] ; and exocytosis in the pituitary gland [26] , placenta [27] and pancreas [28] . As a result, several investigators have suggested that arachidonic acid may be acting as a 'second messenger' [29, 30] according to criteria advanced by Sutherland and co-workers [31] . In most cases, second messengers stimulate the activities of specific protein kinases, which phosphorylate and hence modulate the activity of a large number of enzymes, membrane ion channels and structural proteins [32, 33] . In this context, there are a number of publications showing activation of PKC by arachidonic acid [34] [35] [36] . A major obstacle to the assignment of a PKC as a physiological target of arachidonic acid is the very high concentration needed for enzyme activation (100-600 1M). This obstacle seems to have been overcome with the isolation of PKCy, and the subsequent re-evaluation of the effect of arachidonic acid on this isoenzyme. PKC-y is activated by very low, possibly physiological, concentrations of arachidonic acid (approx. 10 ,M), independent of Ca2 , PS and DG [37, 38] . However, PKC-y is present only in central nervous system tissues [39, 40] , and considerable evidence has accumulated to suggest that arachidonic acid exerts its biological effect as a messenger in other tissues independent of PKC. For example, arachidonic acid stimulates insulin secretion from pancreatic ,8-cells, but not via activation of PKC [41] [42] [43] [44] . Recently the presence of arachidonic acid-activated kinases distinct from PKC, calmodulindependent protein kinase and PKA was reported in pancreatic ,-cells [45] , human platelets [46] and rat liver [47] , suggesting the presence of another target for arachidonic acid as a second messenger, although the molecular aspects of these kinases have not yet been fully clarified. In the present studies we showed that native PKN is distributed ubiquitously and is activated by a low, possibly physiological, concentration of arachidonic acid, suggesting the possibility that PKN is a target for arachidonic acid. Implicating arachidonic acid as a physiological activator requires additional studies at a cellular level and the use of specific inhibitors.
In this study we show that the autophosphorylation activity of PKN is inhibited by pretreatment with alkaline phosphatase. These data suggest that phosphorylation of PKN plays an important role in the activation of PKN activity. A similar case can be presented in support of a regulatory role for phosphorylation in the mitogen-activated protein kinase (MAP kinase) pathway, which uses sequential protein kinase reactions to phosphorylate and activate the next kinase in the pathway. For example, the autophosphorylation activity of purified MAP kinase kinase, a key intermediate in the MAP kinase cascade [48, 49] , is inactivated by phosphatase treatment, and this is correlated with its activator activity [50] . If the PKN activation mechanism is analogous to what is observed in the MAP kinase kinase activation of the MAP kinase pathway, PKN phosphorylation may be the initiating event in PKN activation. A more probable possibility is that the phosphorylation of PKN is either a necessary precursor for cofactor-induced PKN activation and/or a secondary event that stabilizes an active conformation generated by the cofactor-PKN interaction. Further studies to examine the physiological regulation of PKN are under way in our laboratory and should be facilitated by the availability of the purified preparation of the enzyme.
